NASDAQ · HTFL
Healthcare · Medical - Healthcare Information Services
$50.69
Down-$1.33 (-2.62%)
Updated Oct 8, 2026, 12:31 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HTFL
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
HTFL closed at $50.69 after 20 trading sessions, up 8.61% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $54.00 | $54.3195 | $49.51 | $50.69 | 2.91M |
| Oct 5, 2026 | $49.29 | $53.07 | $49.29 | $52.21 | 2.45M |
| Oct 2, 2026 | $49.00 | $50.00 | $47.33 | $49.32 | 1.64M |
| Oct 1, 2026 | $49.81 | $51.08 | $48.84 | $48.91 | 1.28M |
| Sep 30, 2026 | $50.01 | $51.19 | $49.67 | $49.75 | 1.3M |
| Sep 29, 2026 | $50.00 | $50.9999 | $48.67 | $49.83 | 2.04M |
| Sep 28, 2026 | $48.64 | $50.00 | $48.17 | $49.92 | 1.12M |
| Sep 25, 2026 | $48.93 | $49.57 | $48.10 | $49.17 | 1.16M |
| Sep 24, 2026 | $48.32 | $49.07 | $47.23 | $48.66 | 1.52M |
| Sep 23, 2026 | $49.66 | $50.70 | $46.78 | $47.39 | 2.1M |
| Sep 22, 2026 | $50.94 | $51.3999 | $49.71 | $50.17 | 1.35M |
| Sep 21, 2026 | $50.62 | $51.13 | $48.51 | $50.33 | 1.38M |
| Sep 18, 2026 | $50.15 | $52.2212 | $49.28 | $50.75 | 6.61M |
| Sep 17, 2026 | $49.44 | $50.335 | $48.65 | $49.57 | 2.05M |
| Sep 16, 2026 | $48.33 | $49.655 | $47.81 | $48.30 | 2.06M |
| Sep 15, 2026 | $49.28 | $50.44 | $48.19 | $48.33 | 2.03M |
| Sep 14, 2026 | $49.49 | $50.82 | $48.56 | $49.54 | 1.62M |
| Sep 11, 2026 | $46.11 | $50.23 | $45.60 | $49.88 | 2.22M |
| Sep 10, 2026 | $45.99 | $47.805 | $45.41 | $45.49 | 2.26M |
| Sep 9, 2026 | $47.25 | $48.26 | $45.50 | $46.67 | 1.42M |
The latest Smart Investors Daily articles mentioning HTFL.
Company
Market Activity
Research & News
HTFL research
Company profile and research snapshot.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | Canaccord Genuity | Buy | — |
| Sep 9, 2026 | UBS | Neutral | — |
| Aug 14, 2026 | Wells Fargo | Overweight | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
| Aug 14, 2026 | Piper Sandler | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Brown Capital Management, an investment management company, released its second-quarter 2026 investor letter for “The Brown Capital Management Small Company Fund.” The letter can be downloaded here. For the quarter ended June 30, 2026, market volatility reflected uncertainty around AI spending and Middle East tensions. The Magnificent Seven fell more than 8% in June, while […]
Benzinga · Sep 22, 2026
Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.
Yahoo · Sep 17, 2026
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron SMID Cap ETF”. You can download the letter here. Baron SMID Cap ETF® (BCSM) gained 15.62% (NAV) in the second quarter, underperforming the Russell 2500 Growth Index’s 24.02% return. The trend towards “AI winners” continued, focusing on companies related to chips, […]
Yahoo · Sep 15, 2026
The provider of an artificial intelligence-powered cardiac diagnostic platform reported a notable insider stock sale.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HTFL.
